arrow
Back
A

Adil Daud

university of california san francisco

88H-index
622Paper Count
4.8WCitation Count
Published Papers 120
Publication Date
A Technique for the Generation of Mucosal and Acral Melanoma Cell Lines
err2026-09-29
err0
errOAAI
errIshani Banik; Sugandha Basu; Meng Wang; Austin J. Escobar; Veronica Steri; Juan A. Camara Serrano; Paul Phojanakong; Noel Cruz Pacheco; Katy K. Tsai; Edwin A. Alvarez; Adil Daud; Ivan H. El-Sayed; Anastasia Samarkina; Joy Xu; Jamie D. Aquino; Min Xiao; Meenhard Herlyn; Iwei Yeh
errShare
errSave
PURE-seq integrates FACS and PIP-seq for single-cell genomics of ultra-rare cells
err2026-01-21
err0
errOAAI
errSixuan Pan; Inés Fernández-Maestre; Kai-Chun Chang; Stéphane Van Haver; Matthew G. Wereski; Alexandra M. Haugh; Katy K. Tsai; Adil I. Daud; Robert L. Bowman; Harish N. Vasudevan; Ross L. Levine; Adam R. Abate
errShare
errSave
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade–resistant melanoma: Final analysis from a phase 1b study
errCancer
IF5.1
err2025-08-03
err0
errOAAI
errMohammed M. Milhem MD; Yousef Zakharia MD; Diwakar Davar MD, MSc; Elizabeth I. Buchbinder MD; Theresa Medina MD; Adil Daud MD; Antoni Ribas MD, PhD; Bartosz Chmielowski MD, PhD; Jiaxin Niu MD, PhD; Geoffrey T. Gibney MD; Kim Margolin MD, FASCO; Anthony J. Olszanski RPh, MD; Inderjit Mehmi MD; Takami Sato MD, PhD; Montaser Shaheen MD; Luping Zhao PhD; Heather Kelley MA; Hong Liu PhD; Sujatha Kumar PhD; Dmitri Bobilev MD; Arthur M. Krieg MD; James E. Wooldridge MD; John M. Kirkwood MD
errShare
errSave
Intratumoral (ITu) delivery of mRNA-2752 encoding human OX40L/IL-23/IL-36γ in combination with durvalumab induces an immunostimulatory effect within the tumor microenvironment (TME) of patients with advanced solid tumors
err2024-03-22
err1
PREAI
errAbadier, Michael; Sullivan, Ryan J.; Chow, Jacky; Sehgal, Vasudha; Sweis, Randy F.; Daud, Adil; Shapira-Frommer, Ronnie; Perets, Ruth; Kummar, Shivaani; McKean, Meredith; Geva, Ravit; Patel, Manish R.; Khattak, Adnan; Fernandez-Penas, Pablo; Zacharek, Sima; Wahl, Natalia; Walker, Russell M.; Linh Van; Aanur, Praveen; Ward, Jim; Do, Khanh T.; Long, Georgina V.
errShare
errSave
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma
err2024-02-22
err2
errOAAI
errFeichtenschlager, Valentin; Chen, Linan; Zheng, Yixuan James; Ho, Wilson; Sanlorenzo, Martina; Vujic, Igor; Fewings, Eleanor; Lee, Albert; Chen, Christopher; Callanan, Ciara; Lin, Kevin; Qu, Tiange; Hohlova, Dasha; Vujic, Marin; Hwang, Yeonjoo; Lai, Kevin; Chen, Stephanie; Nguyen, Thuan; Munoz, Denise P.; Kohwi, Yoshinori; Posch, Christian; Daud, Adil; Rappersberger, Klemens; Kohwi-Shigematsu, Terumi; Coppe, Jean-Philippe; Ortiz-Urda, Susana
errShare
errSave
Pembrolizumab-associated chronic rhinosinusitis: A new endotype and management considerations
err2023-07-05
err2
errOAAI
errStandiford, Taylor C.; Patel, Neil N.; Singh, Amritpal; Gochman, Grant; Wu, Tara Jamie; Daud, Adil I.; Goldberg, Andrew N.
errShare
errSave
Vidutolimod plus pembrolizumab as 2L+treatment in patients with antiePD-1erefractory melanoma and adrenal insufficiency: Subgroup analyses of a phase Ib study
err2022-09-01
err0
PREAI
errKirkwood, J. M.; Zakharia, Y.; Davar, D.; Buchbinder, E.; Medina, T.; Daud, A.; Ribas, A.; Chmielowski, B.; Niu, J. J.; Gibney, G. T.; Margolin, K. A.; Olszanski, A. J.; Mehmi, I.; Sato, T.; Shaheen, M.; Zhao, L.; Bobilev, D.; Krieg, A. M.; Wooldridge, J.; Milhem, M.
errShare
errSave
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (vol 49, 1148.e1, 2018)
errIMMUNITY
IF26.3
err2022-09-01
err12
errOAAI
errGarris, Christopher S.; Arlauckas, Sean P.; Kohler, Rainer H.; Trefny, Marcel P.; Garren, Seth; Piot, Cecile; Engblom, Camilla; Pfirschke, Christina; Siwicki, Marie; Gungabeesoon, Jeremy; Freeman, Gordon J.; Warren, Sarah E.; Ong, SuFey; Browning, Erica; Twitty, Christopher G.; Pierce, Robert H.; Le, Mai H.; Algazi, Alain P.; Daud, Adil I.; Pai, Sara I.; Zippelius, Alfred; Weissleder, Ralph; Pittet, Mikael J.
errShare
errSave
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor
err2022-06-01
err9
errOAAI
errLee, Jack Y.; Nguyen, Bianca; Mukhopadhyay, Anandaroop; Han, Mia; Zhang, Jun; Gujar, Ravindra; Salazar, Jon; Hermiz, Reneta; Svenson, Lauren; Browning, Erica; Lyerly, H. Kim; Canton, David A.; Fisher, Daniel; Daud, Adil; Algazi, Alain; Skitzki, Joseph; Twitty, Christopher G.
errShare
errSave
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity
err2022-03-18
err11
errOAAI
errHan, Mia; Nguyen, Bianca; Lee, Jack Y.; Browning, Erica; Zhang, Jun; Mukhopadhyay, Anandaroop; Gujar, Ravindra; Salazar, Jon; Hermiz, Reneta; Svenson, Lauren; Rolig, Annah S.; Redmond, William L.; Algazi, Alain P.; Daud, Adil I.; Canton, David A.; Twitty, Christopher G.
errShare
errSave
TCR-sequencing in cancer and autoimmunity: barcodes and beyond
err2022-03-01
err24
errOAAI
errPauken, Kristen E.; Lagattuta, Kaitlyn A.; Lu, Benjamin Y.; Lucca, Liliana E.; Daud, Adil, I; Hafler, David A.; Kluger, Harriet M.; Raychaudhuri, Soumya; Sharpe, Arlene H.
errShare
errSave
Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006
err2021-11-01
err18
errOAAI
errHamid, Omid; Robert, Caroline; Daud, Adil; Carlino, Matteo S.; Mitchell, Tara C.; Hersey, Peter; Schachter, Jacob; V. Long, Georgina; Hodi, F. Stephen; Wolchok, Jedd D.; Arance, Ana; Grob, Jean Jacques; Joshua, Anthony M.; Weber, Jeffrey S.; Mortier, Laurent; Jensen, Erin; Diede, Scott J.; Moreno, Blanca Homet; Ribas, Antoni
errShare
errSave
Layilin Anchors Regulatory T Cells in Skin
err2021-10-01
err13
errOAAI
errMehta, Pooja; Gouirand, Victoire; Boda, Devi P.; Zhang, Jingxian; Gearty, Sofia, V; Zirak, Bahar; Lowe, Margaret M.; Clancy, Sean; Boothby, Ian; Mahuron, Kelly M.; Fries, Adam; Krummel, Matthew F.; Mankoo, Parminder; Chang, Hsin-Wen; Liu, Jared; Moreau, Joshua M.; Scharschmidt, Tiffany C.; Daud, Adil; Kim, Esther; Neuhaus, Isaac M.; Harris, Hobart W.; Liao, Wilson; Rosenblum, Michael D.
errShare
errSave
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment
err2021-03-02
err74
errOAAI
errPauken, Kristen E.; Shahid, Osmaan; Lagattuta, Kaitlyn A.; Mahuron, Kelly M.; Luber, Jacob M.; Lowe, Margaret M.; Huang, Linglin; Delaney, Conor; Long, Jaclyn M.; Fung, Megan E.; Newcomer, Kathleen; Tsai, Katy K.; Chow, Melissa; Guinn, Samantha; Kuchroo, Juhi R.; Burke, Kelly P.; Schenkel, Jason M.; Rosenblum, Michael D.; Daud, Adil I.; Sharpe, Arlene H.; Singer, Meromit
errShare
errSave
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
err2021-02-01
err66
errOAAI
errRobert, Caroline; Hwu, Wen-Jen; Hamid, Omid; Ribas, Antoni; Weber, Jeffrey S.; Daud, Adil, I; Hodi, F. Stephen; Wolchok, Jedd D.; Mitchell (Gangadhar), Tara C.; Hersey, Peter; Dronca, Roxana; Joseph, Richard W.; Boutros, Celine; Min, Le; Long, Georgina, V; Schachter, Jacob; Puzanov, Igor; Dummer, Reinhard; Lin, Jianxin; Ibrahim, Nageatte; Diede, Scott J.; Carlino, Matteo S.; Joshua, Anthony M.
errShare
errSave
SAFETY AND PRELIMINARY EFFICACY OF INTRATUMORAL CAVROTOLIMOD (AST-008), A SPHERICAL NUCLEIC ACID TLR9 AGONIST, IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
err2020-12-10
err10
PREAI
errO'Day, Steven; Perez, Cesar; Wise-Draper, Trisha; Hanna, Glenn; Bhatia, Shailender; Kelly, Ciara; Medina, Theresa; Laux, Douglas; Daud, Adil; Chandra, Sunandana; Shaheen, Montaser; Gao, Ling; Burgess, Melissa; Hernandez-Aya, Leonel; Yeung, Cecilia; Smythe, Kimberly; DeGoma, Emil; Daniel, Weston; Feltner, Douglas; Sindelar, Laurel; Michel, Robert; Bexon, Alice; Bexon, Martin; Milhem, Mohammed
errShare
errSave
INTRATUMORAL INJECTION OF CMP-001, A TOLL-LIKE RECEPTOR 9 (TLR9) AGONIST, IN COMBINATION WITH PEMBROLIZUMAB REVERSED PROGRAMMED DEATH RECEPTOR 1 (PD-1) BLOCKADE RESISTANCE IN ADVANCED MELANOMA
err2020-11-09
err19
PREAI
errMilhem, Mohammed; Zakharia, Yousef; Davar, Diwakar; Buchbinder, Elizabeth; Medina, Theresa; Daud, Adil; Ribas, Antoni; Niu, Jiaxin; Gibney, Geoffrey; Margolin, Kim; Olszanski, Anthony; Mehmi, Inderjit; Sato, Takami; Shaheen, Montaser; Morris, Aaron; Mauro, David; Campbell, Katie; Kelley, Heather; Bao, Riyue; Weiner, George; Luke, Jason; Krieg, Arthur; Wooldridge, James; Kirkwood, John
errShare
errSave